Discussion
Adding Moleculin Biotech’s experimental chemotherapy annamycin to the approved chemotherapy cytarabine may be more effective than cytarabine alone at controlling hard-to-treat acute myeloid leukemia…
Blood cancer is a broad term encompassing diseases in which blood cells grow too much or develop abnormally. Typically, blood cancers are classified into three main categories – leukemia, lymphoma, and myeloma – but they can be further divided into dozens of specific types, each with unique features.
A wide range of therapies are available for treating blood cancer, from chemotherapy and targeted therapy to radiation, stem cell transplant, and surgery. When devising a suitable treatment plan for blood cancer, healthcare providers take into account various factors, such as age, overall health, the specific type of blood cancer, and potential treatment side effects.
Discussion
Adding Moleculin Biotech’s experimental chemotherapy annamycin to the approved chemotherapy cytarabine may be more effective than cytarabine alone at controlling hard-to-treat acute myeloid leukemia…
Discussion
ACUTE MYELOID LEUKEMIA
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the experimental therapy enzomenib (DSP-5336) as a potential treatment for …
Discussion
The experimental anticancer therapy CR-001 was generally well tolerated in a first-in-human clinical trial that tested several doses in 11 people with acute myeloid leukemia…
Acute myeloid leukemia (AML) treatment often involves a combination of several approaches, including chemotherapy, targeted therapies, supportive care, and, for some people, a stem cell…
Acute myeloid leukemia (AML), also called acute myelogenous leukemia, is an aggressive, fast-growing form of blood cancer that starts in immature cells that would…
Acute myeloid leukemia (AML) is a type of blood cancer that develops when genetic changes cause immature blood cells to grow uncontrollably in the…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.